Prof. Juraj Payer, MD, PhD Slovakia Professor of Internal Medicine Vice-president of Slovak Society of Internal Medicine President of Slovak Society for Osteoporosis and Metabolic Bone Diseases Head of the 5th Department of Internal Medicine, Medical Faculty of Comenius University and University Hospital Main expert in Endocrinology, Ministry of Health of the Slovak Republic
1 st IFCA / 5 th IOA 2012 Prague
History and tradition IFCA is a follow-up of the successful cycle I.O.A. (International Osteoporosis Academy). The academy has been extended by gynecology this year. Since 2008 until 2011 over 500 physicians have been educated at 4 postgraduate schools. 4 th IOA 2011 International Osteoporosis Academy 1 at IFCA/ 5 th IOA 2012 International Female Care Academy
International Female Care Academy Hormonal disorders Contraception Climacteric Syndrome HRT Treatment of Osteoporosis
Participants Lithuania Latvia Poland Turkey Ukraine Czech Republic Russia Romania Bulgaria Austria Italy Germany Slovakia 13 countries 150 participants Participants 1 st IOA nd IOA rd IOA th IOA
Live broadcasting The postgraduate school IFCA is broadcast live online Internet website:
Credit of the events IFCA have been accredited by: EACCME European Accreditation Council for Continuing Medical Education at. The EACCME is an institution of the European Union of Medical Specialists (UEMS). IFCA - 8 CME credits
Voting system Questions
What is the capital of the Czech Republic? 1.Berlin 2.Prague 3.Paris
Every doctor is a contraception specialist… 1.Yes 2.More or less …yes 3.No
Do you prescribe contraception ? 1.Yes 2.No 3.Occasionally
Do you prescribe HRT ? 1.Yes 2.No 3.Occasionally
Do you discuss with your patients about osteoporosis ? 1.Yes 2.No 3.Occasionally
Do you prescribe bisphosphonates? 1.Yes 2.No 3.Occasionally
27th APRIL 2012 Block IHormonal Contraceptives in Practices Chairman: Prof. Juraj Payer, MD, PhD (SK) Michael Fanta, MD, PhD (CZ) 9:00 – 9:10Opening ceremonyChairman, Xavier Mesrobian (Zentiva) 9:10 – 9:40Contraceptive management in clinical practiceAssociate Professor Angelo Cagnacci, MD, PhD (IT) 9:40 – 10:00 Overview of the benefits and risks of oral contraceptive use Michael Fanta, MD, PhD (CZ) 10:00 – 10:20 10:20 – 10:50Coffee break 10:50 – 11:10Progestin with a unique cardiovascular profileProf. Juraj Payer, MD, PhD (SK) 11:10 – 11:40Hormonal contraception and boneProf. Miroslav Borovský, MD, PhD (SK) 11:40 – 12:00Discussion 12:00 – 13:00Lunch Block II Bone Health in Women: Whom to Test, Whom to Treat, and How to Treat Chairman: Prof. Juraj Payer, MD, PhD (SK) 13:00 – 13:30Care guide for menopauseProf. Hermann PG Schneider, MD, PhD (DE) 13:30 – 14:00 Postmenopausal woman and OP – Why to treat – epidemiology, patophysiology Prof. Roman Lorenc, MD, PhD (PL) 14:00 – 14:30Coffee break 14:30 – 15:00 Postmenopausal OP – Whom to Test, Whom to treat Prof. Heinrich Resch, MD (AT) 15:00 – 15:30 How to Treat postmenopausal osteoporosis – step by step Prof. Juraj Payer, MD, PhD (SK) 15:20 – 15:30Discussion 28th APRIL 2012 Block IIICare of the Older Woman: Pearls & Pitfalls 9:00 – 9:20Perimenopause and contraceptionMichael Fanta, MD, PhD (CZ) 9:20 – 9:50Osteoporosis case studies Iprof. Alp Cetin, MD (TR) 9:50 – 10:00Coffee break 10:00 – 10:30Osteoporosis case studies IIOlga Růžičková, MD (CZ) 10:30 – 11:00Discussion, closing remarks